应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KROS Keros Therapeutics, Inc.
盘后交易 07-24 19:19:49 EDT
14.38
-0.05
-0.35%
盘后
14.20
-0.18
-1.25%
17:36 EDT
最高
14.74
最低
14.19
成交量
28.77万
今开
14.39
昨收
14.43
日振幅
3.85%
总市值
5.84亿
流通市值
4.05亿
总股本
4,062万
成交额
413.74万
换手率
1.02%
流通股本
2,813万
市净率
0.80
ROE
0.71%
每股收益
0.11
52周最高
72.37
52周最低
9.12
市盈率
131.98
股息
0.00
股息收益率
0.00
ROA
-1.01%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
B of A Securities:下调Keros Therapeutics评级,由买入调整至中性评级, 目标价由32.00美元调整至18.00美元。
金融界 · 06-10
B of A Securities:下调Keros Therapeutics评级,由买入调整至中性评级, 目标价由32.00美元调整至18.00美元。
Keros Therapeutics, Inc.2025财年第一财季实现净利润1.48亿美元,同比增加443.31%
市场透视 · 05-14
Keros Therapeutics, Inc.2025财年第一财季实现净利润1.48亿美元,同比增加443.31%
HC Wainwright & Co.:维持Keros Therapeutics评级,由买入调整至买入评级, 目标价由40.00美元调整至25.00美元。
金融界 · 05-08
HC Wainwright & Co.:维持Keros Therapeutics评级,由买入调整至买入评级, 目标价由40.00美元调整至25.00美元。
Keros Therapeutics, Inc.盘中异动 急速跳水5.22%
市场透视 · 05-06
Keros Therapeutics, Inc.盘中异动 急速跳水5.22%
Keros Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报14.59美元
市场透视 · 04-23
Keros Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报14.59美元
Keros Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%
市场透视 · 04-14
Keros Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%
Keros Therapeutics, Inc.盘中异动 下午盘快速跳水5.10%
市场透视 · 03-10
Keros Therapeutics, Inc.盘中异动 下午盘快速跳水5.10%
Keros Therapeutics, Inc.盘中异动 下午盘股价大涨5.32%
市场透视 · 03-04
Keros Therapeutics, Inc.盘中异动 下午盘股价大涨5.32%
Keros Therapeutics, Inc.2024财年实现净利润-1.87亿美元,同比减少22.22%
市场透视 · 03-02
Keros Therapeutics, Inc.2024财年实现净利润-1.87亿美元,同比减少22.22%
富国银行:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由28.00美元调整至26.00美元。
金融界 · 02-27
富国银行:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由28.00美元调整至26.00美元。
Keros Therapeutics 第四季度每股收益为$(1.14),低于预期$(0.96),销售额为304万美元,低于预期1542万美元
财报速递 · 02-26
Keros Therapeutics 第四季度每股收益为$(1.14),低于预期$(0.96),销售额为304万美元,低于预期1542万美元
“减脂不减肌”:药企竞逐下一代减肥药新突破
老虎资讯综合 · 02-20
“减脂不减肌”:药企竞逐下一代减肥药新突破
Keros Therapeutics, Inc.盘中异动 早盘急速上涨5.32%报10.69美元
市场透视 · 02-14
Keros Therapeutics, Inc.盘中异动 早盘急速上涨5.32%报10.69美元
Keros Therapeutics, Inc.盘中异动 大幅上涨5.03%报11.69美元
市场透视 · 02-06
Keros Therapeutics, Inc.盘中异动 大幅上涨5.03%报11.69美元
Keros Therapeutics, Inc.盘中异动 股价大涨5.00%报11.96美元
市场透视 · 01-23
Keros Therapeutics, Inc.盘中异动 股价大涨5.00%报11.96美元
坎托菲茨杰拉德公司:下调Keros Therapeutics评级
证券之星 · 01-21
坎托菲茨杰拉德公司:下调Keros Therapeutics评级
坎托菲茨杰拉德公司:下调Keros Therapeutics(KROS.US)评级,由增持调整至中性评级。
金融界 · 01-21
坎托菲茨杰拉德公司:下调Keros Therapeutics(KROS.US)评级,由增持调整至中性评级。
Keros Therapeutics, Inc.盘中异动 股价大涨5.06%
市场透视 · 01-21
Keros Therapeutics, Inc.盘中异动 股价大涨5.06%
Piper Sandler:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由40.00美元调整至15.00美元。
金融界 · 01-17
Piper Sandler:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由40.00美元调整至15.00美元。
Wedbush:下调Keros Therapeutics(KROS.US)评级,由优于大市调整至中性评级, 目标价由47.00美元调整至15.00美元。
金融界 · 01-17
Wedbush:下调Keros Therapeutics(KROS.US)评级,由优于大市调整至中性评级, 目标价由47.00美元调整至15.00美元。
加载更多
公司概况
公司名称:
Keros Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
2020-04-08
主营业务:
Keros Therapeutics, Inc.最初于2015年12月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司,专注于为血液学和肌肉骨骼疾病患者开发和商业化新型治疗方法。该公司在了解转化生长因子β(一种蛋白质家族)的作用方面处于领先地位,它是红细胞和血小板生产以及肌肉和骨骼生长、修复和维护的主要调节者。
发行价格:
16.00
{"stockData":{"symbol":"KROS","market":"US","secType":"STK","nameCN":"Keros Therapeutics, Inc.","latestPrice":14.38,"timestamp":1753387200000,"preClose":14.43,"halted":0,"volume":287734,"hourTrading":{"tag":"盘后","latestPrice":14.2,"preClose":14.38,"latestTime":"17:36 EDT","volume":14494,"amount":208422.763396,"timestamp":1753392960907},"delay":0,"floatShares":28132567,"shares":40615414,"eps":0.10896,"marketStatus":"盘后交易","change":-0.05,"latestTime":"07-24 19:19:47 EDT","open":14.39,"high":14.74,"low":14.185,"amount":4137432.4966439996,"amplitude":0.038462,"askPrice":14.65,"askSize":70,"bidPrice":14.11,"bidSize":70,"shortable":3,"etf":0,"ttmEps":0.10896,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1753401600000},"marketStatusCode":4,"adr":0,"listingDate":1586318400000,"exchange":"NASDAQ","adjPreClose":14.43,"preHourTrading":{"tag":"盘前","latestPrice":14.4,"preClose":14.43,"latestTime":"09:29 EDT","volume":229,"amount":3297.138107,"timestamp":1753363799999},"postHourTrading":{"tag":"盘后","latestPrice":14.2,"preClose":14.38,"latestTime":"17:36 EDT","volume":14494,"amount":208422.763396,"timestamp":1753392960907},"volumeRatio":0.4622,"impliedVol":0.4491,"impliedVolPercentile":0.084},"requestUrl":"/m/hq/s/KROS","defaultTab":"news","newsList":[{"id":"2542317949","title":"B of A Securities:下调Keros Therapeutics评级,由买入调整至中性评级, 目标价由32.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2542317949","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542317949?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:10","pubTimestamp":1749561046,"startTime":"0","endTime":"0","summary":"B of A Securities:下调Keros Therapeutics(KROS.US)评级,由买入调整至中性评级, 目标价由32.00美元调整至18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102113589516574c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506102113589516574c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KROS"],"gpt_icon":0},{"id":"2535050077","title":"Keros Therapeutics, Inc.2025财年第一财季实现净利润1.48亿美元,同比增加443.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535050077","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535050077?lang=zh_cn&edition=full","pubTime":"2025-05-14 11:00","pubTimestamp":1747191644,"startTime":"0","endTime":"0","summary":"5月14日,Keros Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为1.48亿美元,同比增加443.31%;其中营业收入为2.11亿美元,同比增加254116.87%,每股基本收益为3.66美元。从资产负债表来看,Keros Therapeutics, Inc.总负债55.69百万美元,其中短期债务2.10百万美元,资产负债比为0.15,流动比率为0.20。机构评级:截至2025年5月14日,当前有9家机构对Keros Therapeutics, Inc.目标价做出预测,其中目标均价为25.67美元,其中最低目标价为15.00美元,最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514110053a47d873e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514110053a47d873e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KROS","LENZ"],"gpt_icon":0},{"id":"2533118578","title":"HC Wainwright & Co.:维持Keros Therapeutics评级,由买入调整至买入评级, 目标价由40.00美元调整至25.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533118578","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533118578?lang=zh_cn&edition=full","pubTime":"2025-05-08 19:01","pubTimestamp":1746702080,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Keros Therapeutics(KROS.US)评级,由买入调整至买入评级, 目标价由40.00美元调整至25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050819080294f06ac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050819080294f06ac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KROS","LENZ"],"gpt_icon":0},{"id":"2533657432","title":"Keros Therapeutics, Inc.盘中异动 急速跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533657432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533657432?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:43","pubTimestamp":1746549827,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时43分,Keros Therapeutics, Inc.股票出现异动,股价快速跳水5.22%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为5.17%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004347a474410c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507004347a474410c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","KROS"],"gpt_icon":0},{"id":"2529388426","title":"Keros Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529388426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529388426?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:26","pubTimestamp":1745418404,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时26分,Keros Therapeutics, Inc.股票出现异动,股价急速上涨5.04%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504232226459742422a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504232226459742422a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","KROS"],"gpt_icon":0},{"id":"2527169311","title":"Keros Therapeutics, Inc.盘中异动 下午盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527169311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527169311?lang=zh_cn&edition=full","pubTime":"2025-04-15 01:23","pubTimestamp":1744651405,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日01时23分,Keros Therapeutics, Inc.股票出现波动,股价大幅拉升5.01%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为2.03%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150123259737a7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150123259737a7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","KROS","BK4139"],"gpt_icon":0},{"id":"2518785153","title":"Keros Therapeutics, Inc.盘中异动 下午盘快速跳水5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518785153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518785153?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:08","pubTimestamp":1741633689,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时08分,Keros Therapeutics, Inc.股票出现异动,股价急速下挫5.10%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103081098a2dd5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103081098a2dd5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KROS","LENZ"],"gpt_icon":0},{"id":"2517856859","title":"Keros Therapeutics, Inc.盘中异动 下午盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517856859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517856859?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:20","pubTimestamp":1741119629,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时20分,Keros Therapeutics, Inc.股票出现波动,股价快速上涨5.32%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042029a25f65f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042029a25f65f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KROS","LENZ"],"gpt_icon":0},{"id":"2516746548","title":"Keros Therapeutics, Inc.2024财年实现净利润-1.87亿美元,同比减少22.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516746548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516746548?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931271,"startTime":"0","endTime":"0","summary":"3月3日,Keros Therapeutics, Inc.公布财报,公告显示公司2024财年净利润为-1.87亿美元,同比减少22.22%;其中营业收入为3.55百万美元,同比增加2250.99%,每股基本收益为-5.00美元。从资产负债表来看,Keros Therapeutics, Inc.总负债44.33百万美元,其中短期债务1.98百万美元,资产负债比为0.14,流动比率为0.22。机构评级:截至2025年3月3日,当前有11家机构对Keros Therapeutics, Inc.目标价做出预测,其中目标均价为33.64美元,其中最低目标价为15.00美元,最高目标价为76.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000149abe4acd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000149abe4acd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KROS","LENZ"],"gpt_icon":0},{"id":"2514338346","title":"富国银行:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由28.00美元调整至26.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338346","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514338346?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:11","pubTimestamp":1740676297,"startTime":"0","endTime":"0","summary":"富国银行:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由28.00美元调整至26.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28011148441551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","KROS"],"gpt_icon":0},{"id":"1125438716","title":"Keros Therapeutics 第四季度每股收益为$(1.14),低于预期$(0.96),销售额为304万美元,低于预期1542万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125438716","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125438716?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:33","pubTimestamp":1740605622,"startTime":"0","endTime":"0","summary":"Keros Therapeutics(LENZ)第四季度每股收益$(1.14),低于预期$(0.96),销售额304万美元,低于预期1542万美元以上内容来自Benzinga Earnings专栏,原文如下:Keros $Therapeutics(LENZ)$ Q4 EPS $(1.14) Misses $(0.96) Estimate, Sales $3.04M Miss $15.42M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KROS","LENZ"],"gpt_icon":0},{"id":"1166835000","title":"“减脂不减肌”:药企竞逐下一代减肥药新突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1166835000","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166835000?lang=zh_cn&edition=full","pubTime":"2025-02-20 17:58","pubTimestamp":1740045485,"startTime":"0","endTime":"0","summary":"罗氏计划今年启动中期试验,将其与自研GLP-1减肥候选药CT-388联用。BiohavenBiohaven在一项早期肥胖试验中评估其靶向肌肉生长抑制素的药物taldefgrobep alfa。该药虽未改善脊髓性肌萎缩症患者的运动功能,但减少了总体脂肪量,并在去脂体重和骨密度方面优于安慰剂。公司将在男性肥胖患者的早期研究中评估安全性,数据预计2025年一季度公布。","market":"us","thumbnail":"https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/f13f2eb23080965f77e2c21530116841"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“减脂不减肌”:药企竞逐下一代减肥药新突破","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","REGN","ELAB","ARWR","LLY","VERU","KROS","SRRK","RHHBY"],"gpt_icon":1},{"id":"2511918296","title":"Keros Therapeutics, Inc.盘中异动 早盘急速上涨5.32%报10.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511918296","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511918296?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:49","pubTimestamp":1739544545,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时49分,Keros Therapeutics, Inc.股票出现异动,股价大幅上涨5.32%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224905a2460546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224905a2460546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","KROS"],"gpt_icon":0},{"id":"2509270755","title":"Keros Therapeutics, Inc.盘中异动 大幅上涨5.03%报11.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509270755","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509270755?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:20","pubTimestamp":1738855237,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时20分,Keros Therapeutics, Inc.股票出现波动,股价快速上涨5.03%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.10%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206232037961a218e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206232037961a218e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KROS","BK4139","LENZ"],"gpt_icon":0},{"id":"2505958026","title":"Keros Therapeutics, Inc.盘中异动 股价大涨5.00%报11.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505958026","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505958026?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:54","pubTimestamp":1737665660,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时54分,Keros Therapeutics, Inc.股票出现异动,股价快速上涨5.00%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为1.77%。消息层面,截至04时54分,《坎托菲茨杰拉德公司:下调Keros Therapeutics评级》资讯为影响Keros Therapeutics, Inc.的重要信息。该信息摘要如下:坎托菲茨杰拉德公司:下调keros Therapeutics评级,由增持调整至中性评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045420abb6447e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045420abb6447e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KROS","BK4139","LENZ"],"gpt_icon":0},{"id":"2505209694","title":"坎托菲茨杰拉德公司:下调Keros Therapeutics评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2505209694","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505209694?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:59","pubTimestamp":1737478781,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:下调keros Therapeutics(KROS.US)评级,由增持调整至中性评级。Keros Therapeutics(KROS.US)公司简介:Keros Therapeutics Inc是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。该公司的蛋白治疗候选产品KER-050正在开发中,用于治疗骨髓增生异常综合征(MDS)患者和骨髓纤维化患者的低血细胞计数或细胞减少症,包括贫血和血小板减少症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010506abb367b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122010506abb367b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KROS","LENZ"],"gpt_icon":0},{"id":"2505420651","title":"坎托菲茨杰拉德公司:下调Keros Therapeutics(KROS.US)评级,由增持调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505420651","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505420651?lang=zh_cn&edition=full","pubTime":"2025-01-22 00:41","pubTimestamp":1737477700,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:下调Keros Therapeutics(KROS.US)评级,由增持调整至中性评级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/22004147678749.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","KROS"],"gpt_icon":0},{"id":"2505427166","title":"Keros Therapeutics, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505427166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505427166?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:33","pubTimestamp":1737469993,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时33分,Keros Therapeutics, Inc.股票出现异动,股价急速上涨5.06%。Keros Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。Keros Therapeutics, Inc.公司简介:Keros Therapeutics Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化新的治疗方法,用于医疗需求未得到满足的患有血液病、肺病和心血管疾病的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223313986e333c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223313986e333c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KROS","LENZ"],"gpt_icon":0},{"id":"2504190183","title":"Piper Sandler:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由40.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504190183","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504190183?lang=zh_cn&edition=full","pubTime":"2025-01-18 02:24","pubTimestamp":1737138299,"startTime":"0","endTime":"0","summary":"Piper Sandler:维持Keros Therapeutics(KROS.US)评级,由增持调整至增持评级, 目标价由40.00美元调整至15.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/18022447578429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","KROS"],"gpt_icon":0},{"id":"2504196967","title":"Wedbush:下调Keros Therapeutics(KROS.US)评级,由优于大市调整至中性评级, 目标价由47.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2504196967","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504196967?lang=zh_cn&edition=full","pubTime":"2025-01-18 00:32","pubTimestamp":1737131532,"startTime":"0","endTime":"0","summary":"Wedbush:下调Keros Therapeutics(KROS.US)评级,由优于大市调整至中性评级, 目标价由47.00美元调整至15.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/18003247578206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["KROS","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.kerostx.com","stockEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0487},{"period":"3month","weight":0.0007},{"period":"6month","weight":0.2188},{"period":"1year","weight":-0.7161},{"period":"ytd","weight":-0.0884}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0568},{"period":"3month","weight":0.1601},{"period":"6month","weight":0.0432},{"period":"1year","weight":0.1452},{"period":"ytd","weight":0.0821}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Keros Therapeutics, Inc.最初于2015年12月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司,专注于为血液学和肌肉骨骼疾病患者开发和商业化新型治疗方法。该公司在了解转化生长因子β(一种蛋白质家族)的作用方面处于领先地位,它是红细胞和血小板生产以及肌肉和骨骼生长、修复和维护的主要调节者。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.013304},{"month":2,"riseRate":0.6,"avgChangeRate":0.081109},{"month":3,"riseRate":0.2,"avgChangeRate":-0.068893},{"month":4,"riseRate":0.4,"avgChangeRate":0.047555},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.095298},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.056826},{"month":7,"riseRate":0.666667,"avgChangeRate":0.017354},{"month":8,"riseRate":0.4,"avgChangeRate":0.085411},{"month":9,"riseRate":0.6,"avgChangeRate":0.029696},{"month":10,"riseRate":0.6,"avgChangeRate":0.145794},{"month":11,"riseRate":0.6,"avgChangeRate":0.149022},{"month":12,"riseRate":0.4,"avgChangeRate":-0.094035}],"exchange":"NASDAQ","name":"Keros Therapeutics, Inc.","nameEN":"Keros Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Keros Therapeutics, Inc.(KROS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Keros Therapeutics, Inc.(KROS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Keros Therapeutics, Inc.,KROS,Keros Therapeutics, Inc.股票,Keros Therapeutics, Inc.股票老虎,Keros Therapeutics, Inc.股票老虎国际,Keros Therapeutics, Inc.行情,Keros Therapeutics, Inc.股票行情,Keros Therapeutics, Inc.股价,Keros Therapeutics, Inc.股市,Keros Therapeutics, Inc.股票价格,Keros Therapeutics, Inc.股票交易,Keros Therapeutics, Inc.股票购买,Keros Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Keros Therapeutics, Inc.(KROS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Keros Therapeutics, Inc.(KROS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}